Free Shipping on Orders over $200
Unlock 10% Off with Email Signup
Same-Day Shipping Before 3 PM EST
$0.00 USD
Tesamorelin is widely studied for its potential role in modulating growth hormone (GH) release. Preclinical research often focuses on its effects on body composition, particularly its influence on visceral fat and metabolic regulation.
Tesamorelin has been observed in laboratory settings to selectively target visceral fat, distinguishing it from other peptides that may influence overall body fat or water retention.
Research literature has noted potential side e ects such as joint discomfort, injection site reactions, and changes in insulin sensitivity. All ndings are limited to controlled experimental settings.
In research environments, Tesamorelin is typically administered once daily due to its short half-life and pulsatile GH release pattern.
Yes, Tesamorelin is supplied as a lyophilized powder and is typically reconstituted with bacteriostatic water under sterile conditions.
CJC-1295 no DAC has a much shorter half-life, leading to rapid clearance and mimicking natural GH release. This version requires more frequent dosing compared to the long-acting DAC form.
Researchers often pair CJC-1295 no DAC with GHRPs like Ipamorelin to synergistically stimulate GH release. This combination is studied for its potential in muscle regeneration and metabolic support.
Due to its short duration of action, protocols often call for 1–2 daily administrations to sustain measurable GH pulses in biological models.
Yes, stacking CJC-1295 no DAC with Ipamorelin is common in GH axis research. The pairing aims to maximize GH release by targeting both GHRH and ghrelin receptor pathways.
Unreconstituted vials should be stored in a cool, dry place. Once mixed, CJC-1295 no DAC should be refrigerated and used within the stability window indicated by the manufacturer.
The DAC version includes a Drug Affinity Complex that extends the peptide’s half-life
significantly—up to several days—making it suitable for weekly dosing in research applications.
Its extended half-life reduces the need for frequent administrations and allows for more stable GH levels in controlled research environments, enhancing study efficiency.
Studies indicate that CJC-1295 DAC remains active for up to 6–8 days, depending on the model and dosage used.
Combining CJC-1295 DAC with GHRPs like GHRP-2 or Ipamorelin may enhance GH release through complementary mechanisms, which is a common area of research interest.
Researchers commonly reconstitute CJC-1295 DAC with 1–2 mL of bacteriostatic water, though volumes may vary depending on the intended concentration.
TB-500 is commonly researched for its regenerative effects on tendons, muscles, and other soft tissues. Research often focuses on its influence on actin regulation and cellular migration.
Preclinical studies suggest TB-500 may promote angiogenesis and reduce inflammation, which can aid in cellular recovery and tissue remodeling.
Initial protocols often use higher loading doses over several weeks, followed by a lower maintenance dose. However, exact schedules vary based on the experimental goals.
Yes, stacking TB-500 with BPC-157 is a popular research approach due to their
complementary effects—BPC-157 often focuses on gut and soft tissue repair, while TB-500 supports cellular migration.
Once reconstituted, TB-500 should be stored in a refrigerator (2°C–8°C) and used within the time frame specified by laboratory guidelines.
BPC-157 is frequently studied for its role in promoting angiogenesis, reducing inflammation, and supporting gastrointestinal lining integrity in preclinical settings.
Both forms are studied, though injectable BPC-157 is often used in experiments involving localized injury repair, while oral forms are explored for GI tract research.
Its ability to influence growth factors and accelerate the healing of ligaments, tendons, and mucosal tissue has made it a frequent subject in regenerative research.
Yes, it is often stacked with TB-500 to explore synergistic effects on soft tissue healing, with both peptides contributing unique support pathways.
Reconstituted BPC-157 should be kept refrigerated and protected from light. It is generally stable for up to 30 days under proper conditions.
Cagrilintide is primarily explored for appetite regulation and weight management. Studies often
focus on how it influences satiety and caloric intake through amylin receptor pathways.
While GLP-1s target insulin response and blood sugar, Cagrilintide mimics amylin, a hormone that helps signal fullness. When combined with GLP-1s, research suggests the effects on appetite and weight loss may be amplified.
Yes—it’s frequently paired with GLP-1 analogs like Semaglutide or Tirzepatide in studies aiming to enhance appetite control and body weight outcomes.
It’s usually administered once per day or every few days, depending on the experimental setup. Its long-acting nature allows for less frequent dosing compared to shorter peptides.
Once mixed, it should be refrigerated and used within the period specified by lab handling standards—typically 20 to 30 days.
Retatrutide is a triple agonist—targeting GLP-1, GIP, and glucagon receptors—and is being explored for its potential effects on weight loss, insulin sensitivity, and metabolic regulation.
Retatrutide has shown promise in early studies for possibly exceeding the metabolic effects of
both Semaglutide and Tirzepatide. Its triple-agonist mechanism may offer broader results in weight loss research.
It targets three key hormone pathways involved in appetite, glucose control, and fat metabolism—making it a cutting-edge subject of interest in advanced obesity and metabolic
studies.
Most studies simulate weekly or biweekly dosing, thanks to its long half-life and sustained activity in metabolic models.
Not usually. Due to its triple action, it’s often studied on its own to isolate its effects—but future research may explore synergistic combinations.
Tirzepatide is widely researched for its dual action on GLP-1 and GIP receptors, which are both tied to glucose regulation, appetite control, and body weight modulation.
It mimics incretin hormones that help manage blood sugar and reduce food intake. Researchers study its impact on both insulin sensitivity and long-term weight trends.
While both influence the GLP-1 pathway, Tirzepatide also activates GIP receptors, which may provide additional metabolic benefits. It’s been noted for potentially stronger outcomes in obesity-related studies.
Weekly dosing is standard in preclinical protocols, as Tirzepatide has a long duration of action and steady hormone support.
In some studies, it’s evaluated alongside Cagrilintide to observe synergistic effects on appetite suppression and fat loss.
Semaglutide is a GLP-1 receptor agonist studied for its role in appetite suppression, glucose regulation, and weight loss. It’s one of the most frequently researched peptides in the metabolic space.
It slows gastric emptying and promotes a strong sense of satiety, which leads to reduced food intake in lab models. This makes it a go-to in obesity-related research.
Weekly injections are standard due to its long-acting profile, which allows researchers to monitor effects over time with fewer administrations.
While it’s commonly studied on its own, researchers sometimes combine it with Cagrilintide to explore multi-pathway appetite suppression.
It should be reconstituted with bacteriostatic water, kept refrigerated, and protected from light. Proper handling helps maintain its stability.
Oxytocin is commonly researched for its influence on trust, bonding, and social behavior. It’s also explored for its potential roles in mood regulation and emotional connection.
It binds to specific receptors in the brain, influencing areas tied to emotional bonding and stress response. Research often investigates its effects on empathy, connection, and anxiety.
No—while intranasal delivery is popular for targeting the brain, some studies use subcutaneous injection depending on the research objective
Yes, some studies explore its impact on physical recovery, lactation mechanisms, and even wound healing due to its influence on smooth muscle and tissue relaxation.
It should be refrigerated after reconstitution and used within the time frame specified by the supplier—usually under 30 days.
GHRP-6 is often explored for its ability to stimulate growth hormone (GH) release. It’s studied for its potential impact on muscle growth, appetite, and recovery.
Research has shown that GHRP-6 may significantly increase appetite, making it useful in studies focused on energy intake, metabolism, and GH axis stimulation.
GHRP-6 is known for its strong appetite-stimulating effects and short half-life. It’s often compared to GHRP-2, which may have less of a hunger spike but similar GH-stimulating
potential.
Due to its fast-acting nature, it’s typically used multiple times per day in studies that aim to mimic natural GH pulses.
Yes, it’s often combined with GHRH analogs like CJC-1295 to amplify GH release through dual-pathway stimulation.
GHRP-2 is studied for its potential to stimulate growth hormone secretion without causing as much appetite increase as GHRP-6. It’s explored for its effects on recovery, lean mass, and aging pathways.
Both stimulate GH, but GHRP-2 typically causes a milder hunger response, making it more favorable for some studies. It may also show a stronger GH spike in certain test conditions.
Protocols usually involve 2–3 doses per day to align with GH secretion rhythms in biological models.
Absolutely—it’s commonly paired with CJC-1295 (DAC or no DAC) to maximize GH release and improve recovery and regeneration potential.
It should be reconstituted with bacteriostatic water and stored refrigerated. Most labs aim to use it within 30 days of mixing.
Selank is often researched for its potential to reduce anxiety, support focus, and improve mood regulation. It’s classified as a nootropic peptide in many experimental studies.
Selank appears to influence neurotransmitters like GABA and serotonin, which are associated with calmness, clarity, and stress response.
Most studies use it in short-term cycles, evaluating effects on memory, anxiety, and cognition within days or weeks.
Yes—research sometimes stacks Selank with Semax or other nootropics to evaluate cognitive enhancement, focus, and resilience under stress.
It’s often delivered intranasally to support direct uptake into the central nervous system, though some studies also explore subcutaneous routes.
IGF-1 (Insulin-like Growth Factor-1) is widely studied for its role in muscle growth, cell regeneration, and longevity. It’s a key part of the GH/IGF axis in biology.
IGF-1 promotes the activation and proliferation of muscle stem cells (satellite cells), which are essential for tissue repair and hypertrophy in muscle research.
Unlike peptides that stimulate GH, IGF-1 works downstream and directly supports cellular repair and anabolism. It’s often evaluated for its regenerative potential.
IGF-1 is often administered daily or every other day in muscle and recovery studies, depending on the protocol being tested.
Yes—it’s sensitive to degradation. It should be reconstituted carefully and stored in a
refrigerator, with limited exposure to light and temperature fluctuations.
MOTS-c is a mitochondrial-derived peptide being explored for its role in energy metabolism, exercise endurance, and insulin sensitivity. It’s a rising star in aging science.
Research suggests MOTS-c helps regulate mitochondrial function and supports cellular energy production, particularly under stress or low-nutrient conditions.
Its mitochondrial origin and ability to cross into the nucleus to influence gene expression set it apart. It’s often explored in the context of metabolic diseases and lifespan studies.
It’s typically administered 2–3 times per week in long-term metabolic or endurance-related experiments.
Yes—some studies explore combining MOTS-c with NAD+ or AMPK-activating compounds to investigate synergistic effects on cellular energy and longevity.
PT-141 (also called Bremelanotide) is widely researched for its potential effects on sexual function, particularly related to arousal and libido in both male and female models.
Unlike compounds that target hormone levels, PT-141 acts directly on the nervous system. It’s believed to stimulate melanocortin receptors in the brain, which influence arousal response.
Yes—it’s studied across sexes, often in the context of sexual motivation, response, and
neurobehavioral patterns tied to desire and satisfaction.
Subcutaneous injection is standard in research environments, allowing for rapid absorption and targeted central effects.
Dosing varies depending on study goals but is typically acute or cyclical—administered only when needed rather than on a continuous schedule.
Sermorelin is studied as a GHRH analog, meaning it stimulates the body’s natural release of growth hormone through pituitary activation.
Sermorelin has a shorter half-life and is more pulsatile in action. It’s considered closer to natural GH release patterns compared to longer-acting alternatives like CJC-1295 DAC.
It’s typically administered 1–2 times daily, often in conjunction with a GHRP like Ipamorelin to support both triggering and amplifying GH release.
Because it mimics the natural hypothalamic signal, pairing it with secretagogues like GHRP-2 or GHRP-6 can create a more robust GH response in lab settings.
Reconstituted Sermorelin should be kept cold (2–8°C) and protected from light. Labs typically use it within 20–30 days.
Lipo-C is a lipotropic injection blend often studied for its potential to support fat metabolism, liver health, and energy production. It typically includes ingredients like MIC (Methionine, Inositol, Choline) and B12.
It’s believed to help mobilize fat from the liver, enhance metabolic activity, and support nutrient processing. Research often explores its role in body composition and fatigue reduction.
Most protocols simulate 2–3 injections per week, depending on study goals related to energy, liver function, or fat metabolism.
Yes—Lipo-C is sometimes studied in conjunction with peptides like Semaglutide or Cagrilintide to evaluate multi-angle support for fat loss and metabolic balance.
Since it’s a pre-mixed blend, it should be refrigerated and shaken gently before use. Shelf life varies based on the compounded formula.
hGH Frag is a modified peptide derived from human growth hormone, primarily studied for its potential to support fat loss without the muscle-building effects of full GH.
It focuses on the region of GH associated with lipolysis (fat breakdown), making it a targeted option in studies exploring weight management.
It’s often administered once or twice daily, ideally on an empty stomach or before cardio, based on studies assessing fat metabolism and thermogenesis.
Yes—it’s frequently paired with metabolic peptides like CJC-1295, Ipamorelin, or Lipo-C for comprehensive fat-burning research stacks.
It should be stored in a refrigerator and protected from light. Most labs use it within 20–30 days of reconstitution.
Ipamorelin is a growth hormone secretagogue often explored for its ability to stimulate GH release without significantly raising cortisol or prolactin.
Ipamorelin is known for its cleaner side effect profile—it’s more selective in its GH release, making it a preferred option in studies focused on muscle gain or recovery.
Dosing is often 1–3 times per day, frequently combined with GHRH peptides like CJC-1295 for synergistic effects.
Yes—one of the most common stacks includes Ipamorelin + CJC-1295, studied for enhanced GH pulses, improved recovery, and cellular regeneration support.
Once reconstituted, it should be refrigerated and used within a month. Proper sterile handling
is critical for stability.
Melanotan 2 is most often researched for its ability to stimulate melanin production and potentially darken skin pigmentation in biological models.
Studies suggest it activates melanocortin receptors, which may lead to increased pigmentation and UV protection in lab subjects.
Yes, some research also explores its effects on libido, appetite, and energy regulation due to its activity on multiple receptor pathways.
It’s typically administered in low, incremental doses over several days to observe gradual pigmentation changes.
It should be refrigerated and used within 30 days of mixing for best stability.
Epitalon is explored for its potential to activate telomerase and support cellular longevity. It’s a popular subject in anti-aging peptide studies.
Studies have investigated Epitalon’s role in DNA repair, oxidative stress reduction, and
circadian rhythm regulation.
Many studies use cyclical dosing (e.g. 10–20 days), repeated periodically, to observe long-term health or aging markers.
Yes—it’s sometimes studied alongside thymic or mitochondrial peptides to evaluate synergistic effects on aging pathways.
After reconstitution, store refrigerated and use within 20–30 days for optimal stability.
GHK-Cu is a copper peptide widely researched for its skin regeneration, wound healing, and anti-aging properties.
It’s believed to promote collagen production, improve skin elasticity, and reduce inflammation in skin tissue models.
Both routes appear in research. Topical use is common in skin repair studies, while injectable formats are used for tissue-level regeneration.
Yes—it’s often stacked with BPC-157 or TB-500 in regenerative research for enhanced healing outcomes.
Store reconstituted GHK-Cu in the refrigerator, avoiding repeated temperature changes.
Kisspeptin-10 is studied for its regulatory role in the reproductive hormone axis, especially in the release of GnRH and downstream sex hormones.
It’s primarily explored in fertility research, puberty onset, and hormonal signaling related to the hypothalamic-pituitary-gonadal axis.
Typically via subcutaneous injection, with short-term protocols designed to monitor hormonal responses.
Yes—it’s occasionally paired with gonadorelin analogs in reproductive studies to observe synergistic effects.
Keep refrigerated and use within 30 days of reconstitution.
AOD-9604 is a fragment of human growth hormone, researched for its potential role in fat metabolism and weight loss support.
It targets fat-burning pathways without the anabolic or insulin-related effects of full growth hormone, making it a focused compound for fat-loss research.
Often administered daily, usually before meals or exercise, to study its effects on lipolysis.
Yes—it’s commonly combined with CJC-1295 or Semaglutide to assess synergy in body composition research.
Refrigerate after mixing and use within the suggested lab timeframe.
It provides the supplies needed to safely and accurately reconstitute lyophilized peptides for research—typically including bacteriostatic water, syringes, and alcohol swabs.
Most reconstitution kits are designed to include bac water as the solvent, but it depends on the supplier.
Yes—as long as sterile technique is maintained and components are not reused across compounds.
Store at room temperature unless otherwise labeled. Opened bac water should be kept in a cool, dark place and discarded after 28–30 days.
No—these kits are sold for laboratory research only and are not intended for human or veterinary use.
This blend is researched for cosmetic and regenerative applications, combining GHK-Cu (skin repair), BPC-157 (healing), and TB-500 (tissue support).
Each contributes uniquely: GHK-Cu for collagen and skin texture, BPC-157 for inflammation and recovery, and TB-500 for cellular migration. Together, they’re studied for comprehensive aesthetic and regenerative support.
esearch often focuses on wound healing, post-procedure recovery, or anti-aging effects on skin and connective tissue.
Both methods appear in lab studies, depending on the targeted tissue and delivery objective.
It should be kept refrigerated and shielded from light once reconstituted.
SS-31 (also known as Elamipretide) is a mitochondrial peptide studied for its protective effects on cellular energy and oxidative stress, particularly in aging and neurodegenerative models.
It specifically targets the inner mitochondrial membrane, helping preserve function and reduce damage from reactive
oxygen species.
Most studies use daily or every-other-day injections to monitor effects on mitochondrial health and fatigue.
Yes—this combination is explored in studies on cellular aging and energy optimization.
Refrigerate after mixing and use within the timeframe indicated by lab handling protocols.
DSIP (Delta Sleep-Inducing Peptide) is researched for its potential role in improving sleep quality, stress adaptation, and hormone regulation.
It’s believed to influence sleep cycles, particularly deep or slow-wave sleep, by acting on neuroendocrine pathways.
Typically short-term protocols are used to evaluate its impact on circadian rhythms and recovery.
Yes—it’s sometimes paired with Selank or Semax in nootropic or recovery-focused experiments.
Store cold and avoid exposure to light or temperature swings.
NAD+ is essential for energy metabolism, cellular repair, and aging. It’s widely researched in anti-aging, brain health, and metabolic regulation.
IV, subcutaneous, or intranasal delivery are all studied—depending on whether the focus is systemic or brain-targeted.
MOTS-c and SS-31 are two common pairings in mitochondrial and anti-aging research.
Dosing varies widely—ranging from daily microdoses to weekly IV-style administrations depending on study type.
NAD+ is sensitive to light and heat—store it refrigerated and use within a short timeframe once reconstituted.
It’s a sterile water solution with a small amount of benzyl alcohol added to inhibit bacterial growth. It’s used to safely reconstitute peptides.
Yes—its preservative allows multi-dose access from the same vial, unlike sterile water for injection which is singleuse.
Most labs discard it after 28–30 days from first use. Keep it in a cool, dark place and maintain sterility.
It is not intended for IV use unless specified by a medical provider. It’s typically used in subcutaneous and lab
reconstitution contexts.
It’s more convenient for multi-use reconstitution and helps reduce contamination risks in ongoing lab work.